- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03541512
Remote Mindfulness Education PLV
November 4, 2023 updated by: Catherine M Leclair, MD, Oregon Health and Science University
Remote Mindfulness-Education Intervention for Women With Provoked Localized Vulvodynia: A Randomized Clinical Study
This is a study designed to learn more about the use of an online remote education and mindfulness practice program for the pain and anxiety associated with provoked localized vulvodynia.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The purpose of study is to evaluate the effectiveness of a remotely delivered mindfulness intervention combined with education for the treatment of the pain and distress associated with Provoked Localized Vulvodynia (PLV).
Women with PLV will be randomized to either an app- based mindfulness program (Headspace®) with online education or online education only.
Pain and sexual distress with be evaluated through a number of measures.
The primary outcome of the study will be the change in distress relating to sexual activity over the 8-week intervention period, which will be measured by a change (reduction) in the Female Sexual Distress Scale (FSDS).
Participants will additionally perform a weekly Tampon Test and fill out a weekly survey regarding their perceived pain as well as the frequency of use and completion of the weekly education materials
Study Type
Interventional
Enrollment (Estimated)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97238
- Oregon Health & Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Reported dyspareunia for at least 3 months in non-pregnant, healthy women over aged 18 years old and estrogen replete with confirmed diagnosis of provoked localized vulvodynia (PVL) or positive Q-tip test, meeting Friedrich's criteria for PLV.
- Ability to insert a regular Tampax® tampon
- Phone access
- Cellular phone with ability to download applications
- Reliable Internet Access
Exclusion Criteria:
- Pregnancy
- Active sexual counseling or mindfulness training (within 6 months of study)
- Any other clinical reason for dyspareunia (endometriosis pain, chronic pelvic pain, vulvar dermatoses such as psoriasis, lichen sclerosus, etc).
- Unable or unwilling to complete baseline assessments or agree to be randomized.
- Non-English speaking, as Headspace® is not validated in other languages
- Actively engaged in a meditative practice
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Mindfulness & Education
Mindfulness practice using guided HeadSpace medications plus educational materials
|
Women in the mindfulness + education group will be asked to meditate daily, 10 minutes a day for the first 4 weeks with the option to increase their time to 20 minutes daily during the second 4 weeks.
Women will also receive educational materials each week addressing different themes such as; "Introduction and Overview", "The Vulva", "Provoked Localized Vulvodynia (PLV)", "Treatment of PVL", "The Pelvic Floor", "Sexuality", "Chronic Pain", and "Promoting Sexual Health".
Other Names:
|
Active Comparator: Education only
Educational materials only
|
Women will also receive educational materials each week addressing different themes such as; "Introduction and Overview", "The Vulva", "Provoked Localized Vulvodynia (PLV)", "Treatment of PVL", "The Pelvic Floor", "Sexuality", "Chronic Pain", and "Promoting Sexual Health".
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Female Sexual Distress Scale (FSDS) at 8 weeks
Time Frame: Baseline & 8 weeks
|
The change in distress relating to sexual activity, measured by a change in the FSDS from baseline (study enrollment) survey.
Participants will complete a Female Sexual Distress Scale (FSDS) survey to rate their feelings associated with sexual activities.
Survey questions are on a number scale of 0 (Never) to 4 (Always).
The FSDS surveys will be completed at baseline and 8 weeks after study enrollment.
|
Baseline & 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Tampon Test Pain Scores at 8 weeks
Time Frame: Baseline & 8 weeks
|
The change in tampon test pain scores (a validated tool that measures introital pain).
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (pain as bad as you can imagine).
This test will occur at baseline and 8 weeks after enrollment.
|
Baseline & 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Catherine Leclair, MD, Oregon Health and Science University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
May 17, 2018
First Submitted That Met QC Criteria
May 17, 2018
First Posted (Actual)
May 30, 2018
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
November 4, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18191
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Provoked Localized Vulvodynia
-
University Hospital, GhentCompletedLocalized Provoked VulvodyniaBelgium
-
Oregon College of Oriental MedicineOregon Health and Science University; National Vulvodynia Association; Council...CompletedVulvodynia | Vulvar Vestibulitis | Provoked Vestibulodynia | Provoked, Localized VulvodyniaUnited States
-
Oregon Health and Science UniversityMedical Research Foundation, OregonCompleted
-
Meir Medical CenterCompleted
-
Meir Medical CenterCompletedLocalized Provoked VulvodyniaIsrael
-
Uppsala UniversityCompletedVulvodynia, Generalized | Provoked VestibulodyniaSweden
-
Oslo Metropolitan UniversityOslo University HospitalCompletedProvoked VestibulodyniaNorway
-
Université de SherbrookeCentre de recherche du Centre hospitalier universitaire de SherbrookeCompleted
-
Hadassah Medical OrganizationTerminatedProvoked VestibulodyniaIsrael
-
University of British ColumbiaCompletedVulvodynia | Provoked Vulvar VestibulodyniaCanada
Clinical Trials on Mindfulness + Education
-
Duke UniversityUniversity of Pennsylvania; University of Washington; National Center for Complementary...CompletedDepression | Anxiety | Psychological Distress | Informal Caregivers | Post-traumatic Stress Disorder | Family MembersUnited States
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ); VA Ann Arbor Healthcare...CompletedEducation, Medical | Mindfulness | Patient Safety | Hand HygieneUnited States
-
T.C. ORDU ÜNİVERSİTESİRecruitingPregnancy Related | Fear of Childbirth | Mindfulness | AttitudeTurkey
-
Oregon Health and Science UniversityCompletedStress, Psychological
-
University of Lausanne HospitalsRecruitingStress | Fibromyalgia | MindfulnessSwitzerland
-
Emory UniversitySatellite HealthcareCompletedHypertension | Renal Failure Chronic Requiring Hemodialysis | Haemodialysis-induced SymptomUnited States
-
University of PittsburghNational Institute on Aging (NIA)Completed
-
Washington University School of MedicineCompletedBurnoutUnited States
-
Taipei Medical UniversityCompleted